Robert E. Slayton

Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A gynecologic oncology group study (a final report)

Robert E. Slayton, Robert C. Park, Steven G. Silverberg et al. · Cancer · 1985 · 168 citations · Full text

Preliminary clinical experience withcis-diamminedichloroplatinum (II) (NSC 119875, CACP)

Arthur H. Rossof, Robert E. Slayton, Charles P. Perlia · Cancer · 1972 · 165 citations · Full text

Drug-related Toxicity, Urology, Oncology +12

Comparative activity and toxicity of cis-diamminedichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinomas of the urinary tract.

Janardan D. Khandekar, Paul Elson, W D DeWys et al. · Journal of Clinical Oncology · 1985 · 91 citations

October 1978, Tumor Biology, Urology +15

Treatment of malignant ovarian germ cell tumors.Response to vincristine, dactinomycin, and cyclophosphamide (preliminary report)

Robert E. Slayton, M.M. Hreshchyshyn, Steven G. Silverberg et al. · Cancer · 1978 · 90 citations

Surgical Oncology, Gynecology, Pathology +17

Clinical study with bleomycin

Sachidananda Shastri, Robert E. Slayton, Janet Wolter et al. · Cancer · 1971 · 69 citations · Full text

Lymphoid Neoplasia, Oncology, Antibiotics +15